|
1
|
Grunewald TGP, Cidre-Aranaz F, Surdez D,
Tomazou EM, de Álava E, Kovar H, Sorensen PH, Delattre O and
Dirksen U: Ewing sarcoma. Nat Rev Dis Primers. 4:52018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arshi A, Sharim J, Park DY, Park HY,
Yazdanshenas H, Bernthal NM and Shamie AN: Prognostic determinants
and treatment outcomes analysis of osteosarcoma and Ewing sarcoma
of the spine. Spine J. 17:645–655. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scotlandi K, Baldini N, Cerisano V, Manara
MC, Benini S, Serra M, Lollini PL, Nanni P, Nicoletti G, Bernard G,
et al: CD99 engagement: An effective therapeutic strategy for Ewing
tumors. Cancer Res. 60:5134–5142. 2000.PubMed/NCBI
|
|
4
|
Riggi N, Cironi L, Provero P, Suvà ML,
Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A and
Stamenkovic I: Development of Ewing's sarcoma from primary bone
marrow-derived mesenchymal progenitor cells. Cancer Res.
65:11459–11468. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gaspar N, Hawkins DS, Dirksen U, Lewis IJ,
Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, et
al: Ewing sarcoma: Current management and future approaches through
collaboration. J Clin Oncol. 33:3036–3046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biermann JS, Chow W, Reed DR, Lucas D,
Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, et
al: NCCN Guidelines Insights: Bone cancer, version 2.2017. J Natl
Compr Canc Netw. 15:155–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arpaci E, Yetisyigit T, Seker M, Uncu D,
Uyeturk U, Oksuzoglu B, Demirci U, Coskun U, Kucukoner M, Isıkdogan
A, et al: Prognostic factors and clinical outcome of patients with
Ewing's sarcoma family of tumors in adults: Multicentric study of
the Anatolian Society of Medical Oncology. Med Oncol. 30:4692013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paulussen M, Ahrens S, Burdach S, Craft A,
Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A
and Jürgens H: Primary metastatic (stage IV) Ewing tumor: Survival
analysis of 171 patients from the EICESS studies. European
Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol. 9:275–281.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferreira AJ, Boldrini E, López RVM,
Scapulatempo Neto C, Santos JF and Lopes LF: Characterization,
survival analysis, and expression of IGFR in tumor samples from
patients diagnosed with Ewing family tumors treated at the Barretos
Cancer Hospital. Rev Bras Ortop. 52:705–713. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodríguez-Galindo C, Liu T, Krasin MJ, Wu
J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM and Navid F:
Analysis of prognostic factors in ewing sarcoma family of tumors:
Review of St. Jude Children's Research Hospital studies. Cancer.
110:375–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grevener K, Haveman LM, Ranft A, van den
Berg H, Jung S, Ladenstein R, Klco-Brosius S, Juergens H, Merks JH
and Dirksen U: Management and outcome of Ewing sarcoma of the head
and neck. Pediatr Blood Cancer. 63:604–610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wan W, Lou Y, Hu Z, Wang T, Li J, Tang Y,
Wu Z, Xu L, Yang X, Song D and Xiao J: Factors affecting survival
outcomes of patients with non-metastatic Ewing's sarcoma family
tumors in the spine: A retrospective analysis of 63 patients in a
single center. J Neurooncol. 131:313–320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ning MS, Perkins SM, Borinstein SC, Holt
GE, Stavas MJ and Shinohara ET: Role of radiation in the treatment
of non-metastatic osseous Ewing sarcoma. J Med Imaging Radiat
Oncol. 60:119–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buja A, Lago L, Lago S, Vinelli A, Zanardo
C and Baldo V: Marital status and stage of cancer at diagnosis: A
systematic review. Eur J Cancer Care (Engl). 27:2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gomez SL, Hurley S, Canchola AJ, Keegan
TH, Cheng I, Murphy JD, Clarke CA, Glaser SL and Martínez ME:
Effects of marital status and economic resources on survival after
cancer: A population-based study. Cancer. 122:1618–1625. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Niu XH: Interpretation of 2020 NCCN
Clinical Practice Guidelines in Oncology-Bone Cancer. Zhonghua Wai
Ke Za Zhi. 58:430–434. 2020.(In Chinese). PubMed/NCBI
|
|
17
|
Coccia PF, Pappo AS, Beaupin L, Borges VF,
Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby
R, et al: Adolescent and young adult oncology, version 2.2018. J
Natl Compr Cancer Netw. 16:66–97. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bacci G, Longhi A, Ferrari S, Mercuri M,
Versari M and Bertoni F: Prognostic factors in non-metastatic
Ewing's sarcoma tumor of bone: An analysis of 579 patients treated
at a single institution with adjuvant or neoadjuvant chemotherapy
between 1972 and 1998. Acta Oncol. 45:469–475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jawad MU, Cheung MC, Min ES,
Schneiderbauer MM, Koniaris LG and Scully SP: Ewing sarcoma
demonstrates racial disparities in incidence-related and
sex-related differences in outcome: An analysis of 1631 cases from
the SEER database, 1973–2005. Cancer. 115:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duchman KR, Gao Y and Miller BJ:
Prognostic factors for survival in patients with Ewing's sarcoma
using the surveillance, epidemiology, and end results (SEER)
program database. Cancer Epidemiol. 39:189–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karski EE, Matthay KK, Neuhaus JM, Goldsby
RE and Dubois SG: Characteristics and outcomes of patients with
Ewing sarcoma over 40 years of age at diagnosis. Cancer Epidemiol.
37:29–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
López Guerra JL, Márquez-Vega C,
Ramírez-Villar GL, Cabrera P, Ordóñez R, Praena-Fernández JM and
Ortiz MJ: Prognostic factors for overall survival in paediatric
patients with Ewing sarcoma of bone treated according to
multidisciplinary protocol. Clin Transl Oncol. 14:294–301. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oksüz DC, Tural D, Dincbas FÖ, Dervisoglu
S, Turna H, Hiz M, Kantarci F, Ceylaner B, Koca S and Mandel NM:
Non-metastatic Ewing's sarcoma family of tumors of bone in
adolescents and adults: Prognostic factors and clinical
outcome-single institution results. Tumori. 100:452–458. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan ZH, Huang ZH and Chen LB: Survival
outcome among patients with Ewing's sarcoma of bones and joints: A
population-based cohort study. Sao Paulo Med J. 136:116–122. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gupta AA, Pappo A, Saunders N, Hopyan S,
Ferguson P, Wunder J, O'Sullivan B, Catton C, Greenberg M and
Blackstein M: Clinical outcome of children and adults with
localized Ewing sarcoma: Impact of chemotherapy dose and timing of
local therapy. Cancer. 116:3189–3194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee J, Hoang BH, Ziogas A and Zell JA:
Analysis of prognostic factors in Ewing sarcoma using a
population-based cancer registry. Cancer. 116:1964–1973. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kreicbergs A, Silvferswärd C and Tribukait
B: Flow DNA analysis of primary bone tumors. Relationship between
cellular DNA content and histopathologic classification. Cancer.
53:129–136. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujii H, Honoki K, Enomoto Y, Kasai T,
Kido A, Amano I, Kumamoto M, Morishita T, Mii Y, Nonomura A and
Takakura Y: Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion
gene: A case report. Virchows Arch. 449:579–584. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Womer RB, West DC, Krailo MD, Dickman PS,
Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP and
Weiss AR: Randomized controlled trial of interval-compressed
chemotherapy for the treatment of localized Ewing sarcoma: A report
from the Children's Oncology Group. J Clin Oncol. 30:4148–4154.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noone AM, Lund JL, Mariotto A, Cronin K,
McNeel T, Deapen D and Warren JL: Comparison of SEER treatment data
with medicare claims. Med Care. 54:E55–E64. 2016. View Article : Google Scholar : PubMed/NCBI
|
